ATE205470T1 - Fluoriertes propranolol und ahnliche verfahren - Google Patents

Fluoriertes propranolol und ahnliche verfahren

Info

Publication number
ATE205470T1
ATE205470T1 AT96940758T AT96940758T ATE205470T1 AT E205470 T1 ATE205470 T1 AT E205470T1 AT 96940758 T AT96940758 T AT 96940758T AT 96940758 T AT96940758 T AT 96940758T AT E205470 T1 ATE205470 T1 AT E205470T1
Authority
AT
Austria
Prior art keywords
fluorinated
propranolol
presented
similar methods
drugs
Prior art date
Application number
AT96940758T
Other languages
English (en)
Inventor
William B Weglicki
I Tong Mak
Hassan Y Aboul-Enein
Original Assignee
Univ George Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ George Washington filed Critical Univ George Washington
Application granted granted Critical
Publication of ATE205470T1 publication Critical patent/ATE205470T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
    • C07C217/30—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36—Antigestagens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/42—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of mineralocorticosteroids

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT96940758T 1995-11-16 1996-11-16 Fluoriertes propranolol und ahnliche verfahren ATE205470T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US683595P 1995-11-16 1995-11-16
US879095P 1995-12-18 1995-12-18
PCT/US1996/017679 WO1997018184A1 (en) 1995-11-16 1996-11-16 Fluorinated propranolol and related methods

Publications (1)

Publication Number Publication Date
ATE205470T1 true ATE205470T1 (de) 2001-09-15

Family

ID=26676127

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96940758T ATE205470T1 (de) 1995-11-16 1996-11-16 Fluoriertes propranolol und ahnliche verfahren

Country Status (9)

Country Link
US (1) US5776985A (de)
EP (1) EP0883596B1 (de)
JP (1) JP2000500451A (de)
AT (1) ATE205470T1 (de)
DE (1) DE69615221T2 (de)
DK (1) DK0883596T3 (de)
ES (1) ES2163661T3 (de)
PT (1) PT883596E (de)
WO (1) WO1997018184A1 (de)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL300886A (de) * 1962-11-23

Also Published As

Publication number Publication date
EP0883596A4 (de) 1999-05-06
WO1997018184A1 (en) 1997-05-22
EP0883596A1 (de) 1998-12-16
US5776985A (en) 1998-07-07
ES2163661T3 (es) 2002-02-01
DK0883596T3 (da) 2002-01-21
DE69615221T2 (de) 2002-06-13
JP2000500451A (ja) 2000-01-18
DE69615221D1 (de) 2001-10-18
PT883596E (pt) 2002-02-28
EP0883596B1 (de) 2001-09-12

Similar Documents

Publication Publication Date Title
ATE184598T1 (de) Enniatine und enniatinderivate zur bekämpfung von endoparasiten
ES2071486T3 (es) Derivado de la 5h-pirrolo(3,4-b)pirazina opticamente activa, su preparacion y las composiciones farmaceuticas que le contienen.
RU94038043A (ru) Применение замещенных производных аденина для лечения множественного склероза
ES2093694T3 (es) Nuevos derivados de dihidro-isoquinoleina.
DK0966447T3 (da) Anvendelige små molekyler til behandling af betændelsessygdomme
TR200002218T2 (tr) 2-(Pürin-9-il)-Tetrahidrofüran -3,4-Diol türevleri
ES2145774T3 (es) Derivados de adenosina que tienen actividad agonista en a2.
ES2184149T3 (es) Paclitaxeles 6-tio sustituidos.
AR022860A1 (es) Derivados de camptotecina que poseen actividad antitumoral
ES2056180T3 (es) Nuevos derivados de 2'-halometiliden, 2'-eteniliden y 2'-etinil citidina.
ES2154262T3 (es) Uso de compuestos macrolidos para enfermedades oculares.
ES2192839T3 (es) Timosina beta 4 oxidada.
DK1056454T3 (da) Anvendelse af makrolidforbindelser til behandling af glaukom
DK0725637T3 (da) Parenteralt busulfan til behandling af malign sygdom
ATE180781T1 (de) Kristallines tiagabinehydrochlorid-monohydrat, seine herstellung und verwendung
DK1037650T3 (da) Præparater til behandling af Staphylococcus aureus-infektioner
FI951511A0 (fi) IL-10:n käyttö insuliinista riippuvan diabetes mellituksen ennaltaestoon tai hoitoon
KR920002151A (ko) 15-케토-프로스타글란딘 화합물에 의한 염증성 질환 치료
ES2100689T3 (es) Asociacion sinergizante que tiene un efecto antagonista de los receptores nk1 y nk2.
NO983177L (no) Anvendelse av 1-enantiomeren av centkroman til fremstilling av et farmasaytisk preparat for behandling eller profylakse av brystkreft
DK578887D0 (da) Antihypertensiva
AR008860A1 (es) Empleo de 1-hidroxi-2-piridonas para el tratamiento de la dermatitis seborreica
ATE160573T1 (de) 1,3.5 (10) - estratriene derivate mit oraler wirkung
CA2137961A1 (en) Cyclic depsipeptides having 18 ring atoms, and their use for combating endoparasites
ATE205470T1 (de) Fluoriertes propranolol und ahnliche verfahren

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee